Douglas Mata

About Douglas Mata

Molecular genetic pathologist with expertise in lab management, biostatistics, and epidemiology.Experience Highlights:• In-depth knowledge of all aspects of solid and liquid tumor diagnosis through morphology (H&E), immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), flow cytometry (FC), DNA-based methylation profiling, and DNA- and RNA-based next-generation sequencing (NGS).• Skilled in standard operating procedure (SOP) design, biomarker discovery and validation, IHC and molecular assay development, quality monitoring and improvement, and technical supervision of laboratory staff in CAP/CLIA/FDA/NYSDOH-regulated environments.• Expertise in statistical software and databases, descriptive and inferential statistics, causal inference methods for real-world data, clinical outcomes analysis using electronic medical record (EMR) data, and clinical trial design and reporting.Publication Highlights:• Track record of leading multi-institutional research teams to high-impact publications in journals such as JAMA, NEJM, and PNAS with work featured by CNN, Newsweek, NYT, TIME, and Washington Post.• Author of the best-selling textbook Statistics for Pathologists, an essential guide that provides a clear, accessible review of the use of statistics in pathology.

Experience

1. Senior Director of Molecular Pathology

   Foundation Medicine

   Mar 2024 — Present · Boston, MA, US

Education

• University of Cambridge

  M.Phil., Public Health

• The Hong Kong University of Science and Technology

  Ambassadorial Scholar, Microbiology

• Rice University

  B.A., Biochemistry and Cell Biology

• Baylor College of Medicine

  M.D.